Recruiting Peripheral T-Cell Lymphoma Studies in Durham
Pacritinib in Relapsed/Refractory T-cell Lymphoproliferative Neoplasms
The main purpose of this study is to determine the effectiveness of the study drug pacritinib in people with relapsed or refractory lymphoproliferative disorders....
Randomized Phase IIB Trial of Oral Azacytidine Plus Romidepsin Versus Investigator's Choice in PTCL
The purpose of this study is to find out whether the combination treatment of romidepsin and oral azacytidine is safe and effective in patients with Peripheral T-Cell Lymphoma (PTCL). This study will ...
About Peripheral T-Cell Lymphoma Clinical Trials in Durham
Peripheral T-cell lymphomas are a diverse group of aggressive non-Hodgkin lymphomas that develop from mature T-cells. They account for about 10-15% of all NHL cases. Treatment includes combination chemotherapy, stem cell transplant, and newer targeted agents.
There are currently 2 peripheral t-cell lymphoma clinical trials recruiting participants in Durham, NORTH%20CAROLINA. These studies are seeking a combined 150 participants. Research is being sponsored by University of Michigan Rogel Cancer Center, University of Virginia. Clinical trial participation is free and participants receive study-related medical care at no cost.
Peripheral T-Cell Lymphoma Clinical Trials in Durham — FAQ
Are there peripheral t-cell lymphoma clinical trials in Durham?
Yes, there are 2 peripheral t-cell lymphoma clinical trials currently recruiting in Durham, NORTH%20CAROLINA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Durham?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Durham research site will contact you about next steps.
Are clinical trials in Durham free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Durham studies also compensate for your time and travel.
What peripheral t-cell lymphoma treatments are being tested?
The 2 active trials in Durham are testing new therapies including novel drugs, biologics, and treatment approaches for peripheral t-cell lymphoma.
Data updated March 2, 2026 from ClinicalTrials.gov